114 related articles for article (PubMed ID: 3316555)
1. Are steroids essential for successful maintenance of immunosuppression in heart transplantation?
Katz MR; Barnhart GR; Szentpetery S; Rider S; Thompson JA; Hess M; Hastillo A; Lower RR
J Heart Transplant; 1987; 6(5):293-7. PubMed ID: 3316555
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial.
Esmore DS; Spratt PM; Keogh AM; Chang VP
J Heart Transplant; 1989; 8(3):194-9. PubMed ID: 2661768
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
[TBL] [Abstract][Full Text] [Related]
5. Impacts of low-dose steroids and prophylactic monoclonal versus polyclonal antibodies on acute rejection in cyclosporine- and azathioprine-immunosuppressed cardiac allografts.
Laufer G; Laczkovics A; Wollenek G; Schreiner W; Sochor H; Holzinger C; Buchelt M; Fasol R; Wolner E
J Heart Transplant; 1989; 8(3):253-61. PubMed ID: 2661776
[TBL] [Abstract][Full Text] [Related]
6. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
7. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation.
Hegewald MG; O'Connell JB; Renlund DG; Lee HR; Burton NA; Karwande SV; Jones KW; Lassetter JE; Bristow MR
J Heart Transplant; 1989; 8(4):303-9; discussion 309-10. PubMed ID: 2504897
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation.
Renlund DG; O'Connell JB; Gilbert EM; Watson FS; Bristow MR
J Heart Transplant; 1987; 6(2):71-8. PubMed ID: 3305832
[TBL] [Abstract][Full Text] [Related]
9. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression.
Canter CE; Moorhead S; Saffitz JE; Huddleston CB; Spray TL
J Heart Lung Transplant; 1994; 13(1 Pt 1):74-9; discussion 79-80. PubMed ID: 8167131
[TBL] [Abstract][Full Text] [Related]
10. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
[TBL] [Abstract][Full Text] [Related]
11. Successful withdrawal of corticosteroids in heart transplantation.
Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
[TBL] [Abstract][Full Text] [Related]
12. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation.
Deeb GM; Kolff J; McClurken JB; Dunn J; Balsara R; Ochs R; Badellino M; Hollander T; Eldridge C; Clancey M
J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833
[TBL] [Abstract][Full Text] [Related]
13. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
[TBL] [Abstract][Full Text] [Related]
14. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
15. Triple-drug immunosuppression for heart transplantation in infants and children.
Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R
J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens.
Gao SZ; Schroeder JS; Alderman EL; Hunt SA; Valantine HA; Wiederhold V; Stinson EB
Circulation; 1989 Nov; 80(5 Pt 2):III100-5. PubMed ID: 2805287
[TBL] [Abstract][Full Text] [Related]
18. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG
J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
[TBL] [Abstract][Full Text] [Related]
19. Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression.
Reid KR; Menkis AH; Novick RJ; Pflugfelder PW; Kostuk WJ; Reid J; Whitby JL; Powell AM; McKenzie FN
J Heart Lung Transplant; 1991; 10(6):894-900. PubMed ID: 1756154
[TBL] [Abstract][Full Text] [Related]
20. Twenty years of heart transplantation at Groote Schuur Hospital.
Reichenspurner H; Odell JA; Cooper DK; Novitzky D; Human PA; Von Oppell U; Becerra E; Boehm DH; Rose A; Fasol R
J Heart Transplant; 1987; 6(6):317-23. PubMed ID: 3320301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
